It is the policy of The University of
Minnesota Duluth, that all scientists, researchers and principal
investigators, who are planning to undertake research projects
involving the use of Hazardous Biological Microorganisms, Biological
Toxins and Artificial Gene Transfer / Recombinant DNA, must submit
Usage Forms and Written Experimental Protocols, to the university
Bio-Safety Officer (BSO) for review and approval, prior to the start of
any such experiments, as required by the University of Minnesota
Institutional Bio-Safety Committee (IBC).
For experiments or work involving
the use of Human Blood, Blood Products and Components, Human Secretion,
Body Fluids, Human Tissues or Organs, compliance with the OSHA
Bloodborne Pathogens Standard (29CFR 1910.1030) is required. No
IBC approval is necessary. However, a submission of a Written
Experimental Protocol is desired.
Written Experimental Protocols must
Also, to insure that safe and prudent
work practices are followed; researchers may commence such experiments
only if all personnel directly or indirectly involved in the handling,
manipulation, containment, decontamination and disposal of known and
potentially infectious bio-hazardous or pathogenic agents and
materials, have had necessary and appropriate training,
were made familiar with the requirements of this plan and will strictly
adhere to the guidelines described herein.
- provide a brief description of
the pathogenicity and public health aspects of the agent used,
- describe the safe methods to be
used for handling, containing and storing the agent, including
Bio-Safety Levels (BSL: 2,3),
- describe the procedure to be
used for decontaminating, area, material and objects during normal
procedure and upon spill of the agent or material.
Biosafety Level 4 (BSL4) is not allowed at UMD.